RELATIONSHIPS AMONG IMMUNOGLOBULIN MARKERS IN GRAVES-DISEASE

被引:62
作者
OZAWA, Y [1 ]
MACIEL, RMB [1 ]
CHOPRA, IJ [1 ]
SOLOMON, DH [1 ]
BEALL, GN [1 ]
机构
[1] UNIV CALIF LOS ANGELES, CTR HLTH SCI, DEPT MED, LOS ANGELES, CA 90024 USA
关键词
D O I
10.1210/jcem-48-3-381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TSH-binding inhibitory activity (TBIA), LATS, and LATS-protector (LATS-P) were examined in sera of 17 patients with untreated Graves' disease (UGD), 17 patients treated for Graves' disease (TGD) and rendered euthyroid, 4 TGD cases not yet euthyroid, 12 patients with euthyroid Graves' disease (EGD), 14 patients with Hashimoto's thyroiditis, and 14 euthyroid relatives of Graves' disease patients. TBIA, LATS, and LATS-P were positive in 69%, 29%, and 100% of UGD sera so studied. Frequency of positive TBIA, LATS, or LATS-P was much less in EGD than in UGD. These activities were undetectable in sera of all patients with Hashimoto's thyroiditis. LATS-P was demonstrable in one Graves' relative, while TBIA or LATS were undetectable in all 14 of them so studied. TBIA was strongly positive in all 10 LATS-positive sera (5 UGD, 4 TGD, and 1 EGD) in this study. It was negative, however, in many sera (5 of 12 UGD, all 7 TGD, all 4 EGD, and the 1 Graves' relative) which were positive for LATS-P without LATS. There was a good correlation (r = 0.59; P < 0.001) between LATS (log response index) and TBIA in 38 Graves' disease sera (17 UGD, 17 TGD, and 4 TGD but still hyperthyroid). However, the r of 0.28 between LATS-P (percentage of protection) and TBIA in 29 LATS-negative sera so studied was not statistically significant (P < 0.2). A patient with Graves' disease demonstrated normally suppressible 24-h thyroid radioiodine uptake after propylthiouracil therapy at a time when TBIA was demonstrable in serum. Similarly, two EGD patients and a relative of a patient with Graves' disease had normal thyroid radioiodine suppression tests in association with a clearly positive LATS-P in the serum. The various data suggest that 1) LATS-P is a more sensitive marker of Graves' disease than LATS or TBIA, and 2) TBIA correlates well with LATS but not as well with LATS-P. The latter finding is consistent with the idea that LATS-P and TBIA are separate activities in Graves' disease, but technical problems prevent a definite conclusion. Additionally, findings in this and other studies of positive LATS-P, TBIA, and/or LATS in some cases with normally suppressible thyroid function raise a question about the significance of these activities, as now estimated, as the sole cause of hyperthyroidism in Graves' disease. © 1979 by The Endocrine Society.
引用
收藏
页码:381 / 387
页数:7
相关论文
共 30 条
[1]  
ADAMS DD, 1975, LANCET, V1, P1201
[2]   EVIDENCE TO SUGGEST THAT LATS PROTECTOR STIMULATES HUMAN THYROID GLAND [J].
ADAMS, DD ;
KENNEDY, TH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (01) :47-+
[3]   STIMULATION OF HUMAN THYROID BY INFUSIONS OF PLASMA CONTAINING LATS PROTECTOR [J].
ADAMS, DD ;
FASTIER, FN ;
HOWIE, JB ;
KENNEDY, TH ;
KILPATRICK, JA ;
STEWART, RDH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 39 (05) :826-832
[4]   OCCURRENCE IN THYROTOXICOSIS OF A GAMMA GLOBULIN WHICH PROTECTS LATS FRON NEUTRALIZATION BY AN EXTRACT OF THYROID GLAND [J].
ADAMS, DD ;
KENNEDY, TH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (02) :173-+
[5]  
ADAMS DD, 1976, AUST NZ J MED, V6, P300, DOI 10.1111/imj.1976.6.4.300
[6]   CORRELATION BETWEEN LONG-ACTING THYROID-STIMULATOR PROTECTOR LEVEL AND THYROID I-131 UPTAKE IN THYROTOXICOSIS [J].
ADAMS, DD ;
KENNEDY, TH ;
STEWART, RDH .
BRITISH MEDICAL JOURNAL, 1974, 2 (5912) :199-201
[7]   SPECIFIC AND NONSPECIFIC RESPONSES IN BIOASSAY OF LONG-ACTING THYROID STIMULATOR (LATS) [J].
CHOPRA, IJ ;
SOLOMON, DH ;
LIMBERG, NP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 31 (04) :382-+
[8]   DISSOCIATION OF SERUM LATS CONTENT AND THYROID SUPPRESSIBILITY DURING TREATMENT OF HYPERTHYROIDISM [J].
CHOPRA, IJ ;
SOLOMON, DH ;
JOHNSON, DE ;
CHOPRA, U ;
FISHER, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 30 (04) :524-+
[9]  
CHOPRA JJ, 1970, METABOLISM, V19, P760
[10]   THYROID-STIMULATING IMMUNOGLOBULINS AND CONTROL OF THYROID-FUNCTION [J].
CLAGUE, R ;
MUKHTAR, ED ;
PYLE, GA ;
NUTT, J ;
CLARK, F ;
SCOTT, M ;
EVERED, D ;
SMITH, BR ;
HALL, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 43 (03) :550-556